OraSure Technologies, Inc.
Regulated industryPhysical productsSells to businessesTags from an AI model reading the company description.
Key Metrics
- Previous Close
- $3.51
- 52-Week Range
- $2.08 – $4.58
- Market Cap
- $247.88M
- P/E (TTM)
- —
- EPS (TTM)
- -0.69
- Dividend Yield
- 0.00%
Advanced Metrics
- Price/Book
- 0.81
- PEG Ratio
- 6.19
- Return on Equity
- -14.50%
- Return on Assets
- -10.94%
- Gross Margin
- 43.12%
- Operating Margin
- -58.18%
- Profit Margin
- -41.73%
- Current Ratio
- 8.58
- Debt/Equity
- 0.04
- Total Debt
- $11.65M
- Free Cash Flow
- $-47.51M
- Revenue Growth
- 14.10%
- Earnings Growth
- —
- Enterprise Value
- $111.29M
Market Snapshot
About
OraSure Technologies, Inc. develops and manufactures diagnostic products and specimen collection devices using oral fluid samples. The company offers rapid point-of-care tests for infectious diseases including HIV, HCV, and COVID-19, as well as molecular collection systems. OraSure focuses on non-invasive diagnostic solutions that provide accurate results and improve patient convenience.